Dr. Christine Lee Hann M.D., PH.D.
Hematologist-Oncologist | Hematology & Oncology
401 N Broadway St Baltimore MD, 21287Rating
5/5
About
Dr. Christine Hann is a hematologist oncologist practicing in Baltimore, MD. Dr. Hann specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Thomas Jefferson University Jefferson Medical College
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2006
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The role of vena caval filters in the management of venous thromboembolism.
- Novel systemic therapies for small cell lung cancer.
- Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells.
- Intratumoral concentrations of imatinib after oral administration in patients with glioblastoma multiforme.
- Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features.
- Bisphosphonamidate clodronate prodrug exhibits potent anticancer activity in non-small-cell lung cancer cells.
- Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo.
- Tumor lysis syndrome in limited-stage small-cell lung cancer.
- Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.
- Rapamycin rescues ABT-737 efficacy in small cell lung cancer.
- A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC.
- A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
Clinical Trials
- A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Delta-Like Protein 3-Expressing Extensive Stage Small Cell Lung Cancer
- Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
- Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC
Awards
- Flight Attendant Medical Research Institute 2007 Young Clinical Scientist Award
- Johns Hopkins University 2006 Pearl M. Stetler Fellowship Award for Women Physicians
- American Society of Clinical Oncology 2005 Young Investigator Award
Treatments
- Lung Cancer
Professional Memberships
- Member American Association for Cancer Research
- Member American Society of Clinical Oncology
Fellowships
- Johns Hopkins University School of Medicine / Hematology and Oncology 2007
Dr. Christine Lee Hann M.D., PH.D.'s Practice location
Practice At 401 N Broadway St
401 N Broadway St -Baltimore, MD 21287Get Direction
Dr. Christine Lee Hann M.D., PH.D.'s reviews
Write ReviewPatient Experience with Dr. Hann
Recommended Articles
![]()
Morphos Declared a "Breakthrough Therapy" for LymphomaMorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
![]()
Daughter's Donation Gives Mom with Lymphoma a Fighting ChanceChyanne Ojageer, a 14-year-old teenager from Kissimmee, Florida, became one of the youngest bone marrow donors in the state when she donated her own bone marrow to help save her mother’s life.Neisha Ojageer, never in her wildest dreams thought that her daughter would be the person to save her...
![]()
How Immunotherapy Makes a Real Difference in Relapsed Hodgkin LymphomaHodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
![]()
The Promising Future of Gene Therapy and LymphomaNon-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
![]()
The Leukemia & Lymphoma Society to Expand Mission Against Blood CancerOn July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
![]()
New Study Discovers How Lymphoma Affects Survivors’ Ability to WorkYoung adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
Nearby Providers
![]()
Dr. Yin Wu MD2401 W BELVEDERE AVE BALTIMORE MD 21215![]()
Ugochukwu A. Odo5406 FAIRLAWN AVE BALTIMORE MD 21215![]()
Dr. Jean Yared M.D.22 S Greene St Baltimore MD 21201![]()
Dr. Young Joo Lee M.D.3001 S Hanover St Brooklyn MD 21225![]()
Dr. Vered Stearns M.D.1800 Orleans St Baltimore MD 21287![]()
Dr. Ashkan Bahrani MD9114 PHILADELPHIA RD BALTIMORE MD 21237
Nearest Hospitals
JOHNS HOPKINS HOSPITAL, THEl
600 NORTH WOLFE STREET BALTIMORE MD 21287KENNEDY KREIGER INSTITUTEl
707 NORTH BROADWAY BALTIMORE MD 21205